▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Dan Carroll

TMFCane

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Recent Articles by Dan Carroll

Aug 9, 2013 by Dan Carroll

Alcoa's Surge Can't Save the Dow's Decline

The index is on pace to snap its recent growth streak as most blue chip stocks recede.

Aug 9, 2013 by Dan Carroll

Will This Acquisition Ignite Brazil's Health Care Potential?

GE makes a big health care buy in one of the world's hottest markets.

Aug 9, 2013 by Dan Carroll

3 Rising Stars in the Medical Device Industry

Here's three stocks full of potential -- if their companies make the right moves today to secure a future full of bright possibilities

Aug 9, 2013 by Dan Carroll

Can AstraZeneca's New Strategy Save Its Stock?

This big pharma has had a tough time over the past few years, but is its future worth your investment?

Aug 8, 2013 by Dan Carroll

Microsoft's Bounce Headlines the Dow's Rebound

After a bad start to the day, stocks have recovered nicely to rise into the green.

Aug 7, 2013 by Dan Carroll

Better Dividend: Johnson & Johnson vs. Pfizer

Two of health care's top stocks go head to head for income investors. Which one is your best bet?

Aug 7, 2013 by Dan Carroll

Disney's Earnings Pessimism Pulls the Dow Lower

DuPont rises, but can't outweigh falling stocks across the markets

Aug 6, 2013 by Dan Carroll

IBM's Plunge Leads the Dow's Big Drop

Disney's earnings optimism keeps the index from even bigger losses.

Aug 5, 2013 by Dan Carroll

UnitedHealth Outshines a Downbeat Dow

The markets are slipping, but this is one blue chip with plenty of upside.

Aug 4, 2013 by Dan Carroll

Investing in the Worst Market in the World

China's markets have taken a dive with the country's slowdown. Can investors still find top stocks in the world's second-largest economy?

Aug 2, 2013 by Dan Carroll

Is Japan's Surging Stock Market Hiding a Dangerous Risk?

Investors have profited handsomely from Japan's surge this year, but will the Nikkei keep up its run?

Aug 2, 2013 by Dan Carroll

The Hang Seng's Bounce Hasn't Stopped China's Slowdown

Chinese stocks may have had a good July, but the country's economic problems are far more deeply rooted

Aug 2, 2013 by Dan Carroll

Germany's Auto Market Picks Up as the DAX Runs Higher

German industrial giant Siemens is in trouble following a major shakeup, but auto stocks VW and BMW could be ready to run.

Aug 2, 2013 by Dan Carroll

Why Big Oil's Taking Down the Dow

Exxon and Chevron shares are falling after both miss on analyst expectations.

Aug 1, 2013 by Dan Carroll

The Dow Follows Manufacturing Higher

The U.S. PMI soars in July, sending shares of the Dow's leading industrial giants higher.

Jul 31, 2013 by Dan Carroll

3 Shocking Numbers on Diabetes' Grim Future

Diabetes has become a global epidemic, but for companies in this industry, tomorrow's biggest windfalls could be immense.

Jul 31, 2013 by Dan Carroll

Today's 3 Worst Stocks

J.C. Penney's nosedive highlights the S&P 500's big laggards on the day.

Jul 31, 2013 by Dan Carroll

The Dow Gives Up Its Gains Despite Bank of America's Jump

Little news from the Fed keeps Wall Street in a holding pattern.

Jul 31, 2013 by Dan Carroll

Is More Patent Pain Headed Merck's Way?

Singulair's patent expiration has hit Merck hard, but more high-profile drugs are set to lose patent protection soon.

Jul 31, 2013 by Dan Carroll

Better Dividend: Abbott vs. AbbVie

Abbott and its former pharmaceuticals business go head to head to find the better dividend for your portfolio.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services